Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis

BACKGROUND: Intraperitoneal chemotherapy using paclitaxel is considered an experimental approach for treating peritoneal carcinomatosis. This study aimed to determine the recommended dose, and to evaluate the clinical efficacy and safety, of the combination of intravenous gemcitabine, intravenous na...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, S., Fujii, T., Yamamoto, T., Takami, H., Yoshioka, I., Yamaki, S., Sonohara, F., Shibuya, K., Motoi, F., Hirano, S., Murakami, Y., Inoue, H., Hayashi, M., Murotani, K., Kitayama, J., Ishikawa, H., Kodera, Y., Sekimoto, M., Satoi, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689756/
https://www.ncbi.nlm.nih.gov/pubmed/32638367
http://dx.doi.org/10.1002/bjs.11792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689756/
https://www.ncbi.nlm.nih.gov/pubmed/32638367
http://dx.doi.org/10.1002/bjs.11792

Ejemplares similares